Treatment of a Tuberculous Empyema with Simultaneous Oral and Intrapleural Antituberculosis Drugs

Author:

Long Richard1,Barrie James2,Stewart Kenneth3,Peloquin Charles A4

Affiliation:

1. Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

2. Department of Radiology, University of Alberta, Edmonton, Alberta, Canada

3. Department of Surgery, University of Alberta, Edmonton, Alberta, Canada

4. Infectious Disease Pharmacokinetics Laboratory, National Jewish Medical and Research Center, Denver, Colorado, USA

Abstract

A 71-year-old man was diagnosed with an uncomplicated tuberculous (TB) empyema. Differential penetration of anti-TB drugs, believed to explain the phenomenon of acquired drug resistance in TB empyema, was confirmed by measurement of serum and pleural fluid anti-TB drug concentrations. Simultaneous oral and intrapleural anti-TB drugs were administered and a cure was achieved. The present case is discussed in the context of the literature on acquired drug resistance in TB empyema. It is argued that high-end doses of oral drugs or combined oral plus intrapleural drugs, along with tube thoracostomy or intermittent thoracentesis, will cure uncomplicated TB empyema without threatening to induce drug resistance or having to resort to surgery.

Publisher

Hindawi Limited

Subject

Pulmonary and Respiratory Medicine

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. The tuberculous pleural effusion;Breathe;2023-12

2. Chapitre 8: La tuberculose pharmacorésistante;Canadian Journal of Respiratory, Critical Care, and Sleep Medicine;2023-11-02

3. Chapitre 7: La tuberculose extrapulmonaire;Canadian Journal of Respiratory, Critical Care, and Sleep Medicine;2023-11-02

4. A physiologically‐based pharmacokinetic model for tuberculosis drug disposition at extrapulmonary sites;CPT: Pharmacometrics & Systems Pharmacology;2023-07-16

5. Chapter 8: Drug-resistant tuberculosis;Canadian Journal of Respiratory, Critical Care, and Sleep Medicine;2022-03-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3